Answers are grounded in this paper and cite their sources.
Rational structure-based drug design (SBDD) depends on high-resolution structural models of target macromolecules or their complexes. However, the lack of atomic-level functional molecular dynamics hinders the applications of SBDD and limits their effective translation into clinically successful therapeutics. Time-resolved cryo-electron microscopy (cryo-EM) has emerged as a powerful tool in structural biology, capable of capturing high-resolution snapshots of biomolecular machines in action. Unlike molecular dynamics (MD) simulations, time-resolved cryo-EM can visualize rare intermediate states across a broader range of timescales, providing invaluable insights into drug-binding kinetics, dynamic protein-ligand interactions, and allosteric regulation. Integration of time-resolved cryo-EM with machine learning (ML) and artificial intelligence (AI) expands SBDD into a dynamics-based approach, allowing for more accurate pharmacological modeling of challenging drug targets that are beyond the reach of MD simulations. Time-resolved cryo-EM can help researchers to identify novel druggable conformations, overcome drug resistance, and reduce the time and cost of clinical translations. Despite current challenges, the future development of time-resolved cryo-EM with AI and in situ imaging strategy, such as cryo-electron tomography, holds the potential to revolutionize drug discovery by revealing in vivo molecular dynamics of drug actions at an unprecedented spatiotemporal scale.
No takes yet. Share an insight, caveat, or question.
Youdong Mao (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: